Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.|Both authors contributed equally.
Els
E
Van Kampenhout
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.|Both authors contributed equally.
Mathieu S
MS
Bolhuis
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
Jan-Willem C
JC
Alffenaar
Franciscus Gasthuis en Vlietland Teaching Hospital, Rotterdam, The Netherlands.
Laurien M A
LM
Oswald
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
Huib A M
HA
Kerstjens
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.|University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Wiel C M
WC
de Lange
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.|University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The Netherlands.
Tjip S
TS
van der Werf
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands o.w.akkerman@umcg.nl.|University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Onno W
OW
Akkerman
D000328:Adult; D000995:Antitubercular Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D005260:Female; D024841:Fluoroquinolones / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006801:Humans; D000069349:Linezolid / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D000077266:Moxifloxacin; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011247:Pregnancy; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*
D000995:Antitubercular Agents; D024841:Fluoroquinolones; D000069349:Linezolid; D000077266:Moxifloxacin